Inlyta Prices, Coupons, Copay Cards & Patient Assistance
Inlyta (axitinib) is a member of the multikinase inhibitors drug class and is commonly used for Renal Cell Carcinoma.
Inlyta is available as a brand name drug only, a generic version is not yet available. View generic Inlyta availability for more details.
Inlyta prices
Oral Tablet
1 mg Inlyta oral tablet from $20,678.94 for 180 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 180 | $114.88 | $20,678.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
5 mg Inlyta oral tablet from $20,678.94 for 60 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 60 | $344.65 | $20,678.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Inlyta Coupons, Copay Cards and Rebates
Inlyta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Inlyta Pfizer Oncology Together Co-Pay Savings Card
Eligible commercially insured patients may pay as little as $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
- Applies to:
- Inlyta
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Inlyta Pfizer Oncology Together Co-Pay Savings Program Rebate
Eligible commercially insured patients may submit a request for a rebate in connection with this offer if their pharmacy does not participate in the program; for additional information contact the program at 877-744-5675.
- Applies to:
- Inlyta
- Number of uses:
- One rebate per prescription fill
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Inlyta Medicare Part D Extra Help Subsidy
Patients with Medicare Part D coverage may be eligible for the Extra Help Subsidy, which can lower premiums and prescription costs. Contact the program for more information.
- Applies to:
- Inlyta
- Number of uses:
- Per prescription until program expires
Form more information phone: 800-772-1213 or Visit website
Patient Assistance & Copay Programs for Inlyta
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Inlyta (axitinib)
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Inlyta (axitinib) Tablet
More information please phone: 866-316-7263 Visit website
Provider: Pfizer Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured
- Varies
- Not specified
- Must be residing in the US or US territory
- Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
- Inlyta (axitinib) Tablet
More information please phone: 866-706-2400 Visit website
Provider: Pfizer Oncology Together
Eligibility requirements:- Contact program for details.
- At or below 300% of FPL
- FDA-approved diagnosis
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Inlyta (axitinib) Tablet
More information please phone: 877-744-5675 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Inlyta (axitinib)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español